Zosano Pharma (ZSAN) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 65 254 sessions, June 10, 2021 to June 10, 2022
- Largest daily move
- -48.6% close of February 9, 2022
- 1-year change
- -98.3% closing prices, June 10, 2021 to June 10, 2022
- 1-month change
- -68.8% closing prices, May 10, 2022 to June 10, 2022
Company Description
Zosano Pharma (Nasdaq: ZSAN) is classified in the biotechnology industry within the Healthcare sector.
ZSAN declined 98.3% in the 12 months to June 10, 2022. The last closing price was $0.5576.
This page collects what Stock Titan holds for ZSAN, including price data and latest news.
Stock Performance
Zosano Pharma (ZSAN) closed at $0.5576 on June 10, 2022. In the 12 months to June 10, 2022, the price lost 98.3%.
ZSAN Metrics & Rankings
Price returns through June 10, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Zosano Pharma has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, stock split, offering, clinical trial, management. View all ZSAN news →
SEC Filings
ZSAN Company Profile & Sector Positioning
Zosano Pharma (ZSAN) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ZSAN often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZSAN's relative position within its industry.